ArticleThe Korean journal of internal medicine2023
Sofosbuvir-velpatasvir and sofosbuvir-velpatasvir-voxilaprevir: novel treatment options for naïve and previously treated hepatitis C infection.
Hyun Phil ShinPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.